Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2022-10-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xml |
_version_ | 1811229944831803392 |
---|---|
author | Hiroshi Arima Timothy Cheetham Mirjam Christ-Crain Deborah Cooper Mark Gurnell Juliana B Drummond Miles Levy Ann I McCormack Joseph Verbalis John Newell-Price John A H Wass |
author_facet | Hiroshi Arima Timothy Cheetham Mirjam Christ-Crain Deborah Cooper Mark Gurnell Juliana B Drummond Miles Levy Ann I McCormack Joseph Verbalis John Newell-Price John A H Wass |
author_sort | Hiroshi Arima |
collection | DOAJ |
description | ‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of ‘diabetes insipidus’ to ‘arginine vasopressin deficiency (AVP-D)’ for central etiologies, and ‘arginine vasopr essin resistance (AVP-R)’ for nephrogenic etiologies. This article provides both the historical context and the rationale for this proposed name change. |
first_indexed | 2024-04-12T10:21:42Z |
format | Article |
id | doaj.art-a0532482c3394a2caccb512e87e17c8f |
institution | Directory Open Access Journal |
issn | 2049-3614 |
language | English |
last_indexed | 2024-04-12T10:21:42Z |
publishDate | 2022-10-01 |
publisher | Bioscientifica |
record_format | Article |
series | Endocrine Connections |
spelling | doaj.art-a0532482c3394a2caccb512e87e17c8f2022-12-22T03:37:05ZengBioscientificaEndocrine Connections2049-36142022-10-01111114https://doi.org/10.1530/EC-22-0378Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes InsipidusHiroshi Arima0Timothy Cheetham1Mirjam Christ-Crain2Deborah Cooper3Mark Gurnell4Juliana B Drummond5Miles Levy6Ann I McCormack7Joseph Verbalis8John Newell-Price9John A H Wass10Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Japanese Endocrine Society Department of Paediatric Endocrinology, Newcastle University Faculty of Medical Sciences, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK; European Society for Pediatric EndocrinologyDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, University of Basel, Switzerland; European Society of EndocrinologyPituitary Foundation, Bristol, UKEuropean Society of Endocrinology; Wellcome-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, UKFaculdade de Medicina da UFMG, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Brazilian Society of Endocrinology and Metabolism Endocrinology, University Hospitals of Leicester, Leicester, UK; Society for EndocrinologyHormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Endocrine Society of Australia Endocrinology and Metabolism, Georgetown University Medical Center, Washington DC, District of Columbia, USA; Endocrine Society Endocrine Society; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UKDepartment of Endocrinology, Oxford Centre for Diabetes Endocrinology & Metabolism – Endocrinology, Oxford, UK; Pituitary Society ‘What’s in a name? That which we call a rose/By any other name would smell as sweet’ (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare’s implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of ‘diabetes insipidus’ to ‘arginine vasopressin deficiency (AVP-D)’ for central etiologies, and ‘arginine vasopr essin resistance (AVP-R)’ for nephrogenic etiologies. This article provides both the historical context and the rationale for this proposed name change.https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xmlrenamingdiabetes insipidus |
spellingShingle | Hiroshi Arima Timothy Cheetham Mirjam Christ-Crain Deborah Cooper Mark Gurnell Juliana B Drummond Miles Levy Ann I McCormack Joseph Verbalis John Newell-Price John A H Wass Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus Endocrine Connections renaming diabetes insipidus |
title | Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus |
title_full | Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus |
title_fullStr | Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus |
title_full_unstemmed | Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus |
title_short | Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus |
title_sort | changing the name of diabetes insipidus a position statement of the working group for renaming diabetes insipidus |
topic | renaming diabetes insipidus |
url | https://ec.bioscientifica.com/view/journals/ec/11/11/EC-22-0378.xml |
work_keys_str_mv | AT hiroshiarima changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT timothycheetham changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT mirjamchristcrain changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT deborahcooper changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT markgurnell changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT julianabdrummond changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT mileslevy changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT annimccormack changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT josephverbalis changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT johnnewellprice changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus AT johnahwass changingthenameofdiabetesinsipidusapositionstatementoftheworkinggroupforrenamingdiabetesinsipidus |